3/12/2018 | IG | Moody's lowers Daiichi Sankyo
|
6/10/2016 | IG | Moody’s changes Daiichi Sankyo to negative
|
10/27/2008 | CV | Ranbaxy holders may now convert 0% convertibles
|
9/21/2006 | BT | Novartis, Daiichi to end OTC medicine contract in December
|
9/8/2006 | BT | Daiichi Sankyo to invest $60 million in Kearney Venture Partners
|
8/31/2006 | BT | Sankyo, Ajinomoto to develop new diabetes drug, AJD101
|
8/2/2006 | BT | Daiichi Sankyo units file patent infringement suit against Mylan for Benicar
|
7/14/2006 | BT | Daiichi, Lilly sign European agreement for osteoporosis drug Evista
|
6/20/2006 | BT | Daiichi to continue SUN-N8075 clinical development
|
6/16/2006 | BT | Daiichi Sankyo's subsidiary certified to import, sell pharmaceutical products in China
|
6/12/2006 | BT | Daiichi says Welchol improves glycemic control
|
4/27/2006 | BT | Sankyo selects Evotec as assay development, screening partner
|
4/24/2006 | BT | Asahi Breweries to acquire Daiichi Sankyo's Wakoda unit
|
4/18/2006 | BT | Daiichi Sankyo: WelChol added to statin therapy reduces median hs-CRP levels
|
3/23/2006 | BT | Daiichi Pharma Holdings, Sankyo Pharma to form Daiichi Sankyo Inc.
|
3/20/2006 | BT | Exelixis, Sankyo sign $20 million deal to develop therapies for cardiovascular disease
|
3/16/2006 | BT | MorphoSys, Daiichi Sankyo form alliance to develop antibody therapies
|
2/6/2006 | BT | S&P rates Daiichi Sankyo A+
|
1/24/2006 | BT | Daiichi to manufacture poultice analgesic
|
12/22/2005 | BT | Daiichi says appeals court upholds decision against allowing Mylan's generic levofloxacin
|
11/17/2005 | BT | Daiichi Sankyo's 12-year study shows Mevalotin curbs cardiovascular disease in high-cholesterol patients
|
10/26/2005 | BT | Daiichi Sankyo ends pactimibe CS-505 clinical studies after finding no benefit
|
9/28/2005 | BT | Moody's affirms Daiichi, Sankyo
|